Purification of untagged HIV-1 reverse transcriptase by affinity chromatography

Area of Science:

• Biochemistry
• Virology
• Drug Development

Background:

• Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a critical target for antiviral therapies.
• The emergence of drug-resistant HIV-1 strains necessitates continuous development of new antiviral agents.
• Efficient purification of HIV-1 RT variants is crucial for evaluating drug resistance profiles.

Purpose of the Study:

• To develop simplified and rapid purification protocols for untagged wild-type and mutant HIV-1 RT.
• To reduce the time and complexity of traditional HIV-1 RT purification methods.
• To facilitate the assessment of novel drug candidates against HIV-1.

Main Methods:

• A one-step affinity purification using an RNase H specific inhibitor (RNHI) conjugated to resin, with elution via EDTA.
• A two-step purification involving a C-terminal cleavable intein and AviTag fusion, DE-52 chromatography, and avidin affinity purification.
• Reductive cleavage with DTT to release untagged RT after affinity purification.

Main Results:

• Two novel methods significantly shorten the time required for purifying untagged HIV-1 RT.
• The developed protocols yield highly active untagged wild-type and mutant RT.
• These methods enable efficient purification in one or two steps, compared to traditional multi-column approaches.

Conclusions:

• The novel purification methods offer a significant improvement over traditional protocols for HIV-1 RT purification.
• These simplified methods will accelerate the evaluation of antiviral compounds and resistance profiles.
• The developed techniques are valuable tools for HIV-1 drug discovery and development efforts.